Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.48 +0.88 (+8.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer

June 05, 2023

Via ACCESSWIRE

NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference

June 01, 2023

Via ACCESSWIRE

NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO

May 30, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023 ↗

May 16, 2023

Via Benzinga

NeoGenomics's Return On Capital Employed Insights ↗

May 15, 2023

Via Benzinga

NeoGenomics: Q1 Earnings Insights ↗

May 12, 2023

Via Benzinga

NeoGenomics Reports Q1 Topline Growth, Lifts Annual Guidance, Shares Soar ↗

May 09, 2023

NeoGenomics Inc (NASDAQ: NEO) reported Q1 revenues of $137.22 mill

Via Benzinga

Analyst Expectations for NeoGenomics's Future ↗

May 09, 2023

Via Benzinga

Earnings Scheduled For May 12, 2023 ↗

May 12, 2023

Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.

Via Benzinga

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

NeoGenomics Reports First Quarter 2023 Results

May 08, 2023

Via ACCESSWIRE

What 9 Analyst Ratings Have To Say About NeoGenomics ↗

April 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023 ↗

May 09, 2023

Via Benzinga

McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday ↗

May 09, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference

May 03, 2023

Via ACCESSWIRE

Looking Into NeoGenomics's Return On Capital Employed ↗

March 30, 2023

Via Benzinga

Analyst Ratings for NeoGenomics ↗

March 03, 2023

Via Benzinga

Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know ↗

February 24, 2023

Via Benzinga

NeoGenomics, Inc. (NASDAQ:NEO) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗

April 20, 2023

San Diego, CA -- (SBWIRE) -- 04/20/2023 -- An investigation concerning potential breaches of fiduciary duties by certain directors and officers of NeoGenomics, Inc was announced.

Via SBWire

NeoGenomics to Announce First Quarter 2023 Financial Results

April 17, 2023

Via ACCESSWIRE

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

April 11, 2023

Via ACCESSWIRE

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

April 06, 2023

Via ACCESSWIRE

NeoGenomics to Host Investor Day on April 4, 2023

March 27, 2023

Via ACCESSWIRE

Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

March 22, 2023

From Massive Bio, Inc.

Via Business Wire

Why Shares of NeoGenomics Jumped Today ↗

February 23, 2023

The company released promising earnings results.

Via The Motley Fool

3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing ↗

March 19, 2023

The high-flyers have soared to new heights and further gains could be up ahead.

Via The Motley Fool

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

March 16, 2023

Via ACCESSWIRE

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

March 13, 2023

Via ACCESSWIRE

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

February 28, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023 ↗

February 24, 2023

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today